Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Med Vision Secures Series A+ Funding to Expand Digital Therapy Portfolio
January 25, 2025
Company
Drug
Kexing Pharmaceutical Initiates Phase I Trial for IFN-Alpha-1b Inhalation Solution
February 12, 2025
Company
Deals
Bioantibody Bio Raises RMB 100 Million in Series A Funding Round
January 25, 2025
Company
Deals
Meihua Partners with Getein Biotech to Manufacture COVID-19 Antigen Tests
January 25, 2025
Company
Drug
CSPC’s Cleviprex Approved for Clinical Study by China’s NMPA
January 25, 2025
Policy / Regulatory
China’s Dental Implant VBP Tender Results in Significant Price Cuts
January 25, 2025
Company
Drug
Takeda’s Mobocertinib Approved in China for EGFR Exon20ins NSCLC
January 25, 2025
Company
Deals
MediTrust Health Secures Series C+ Funding with HSBC as Strategic Investor
January 25, 2025
Company
Drug
Kelun-Biotech’s SKB264 Approved for Phase II Study in EGFR-Mutant NSCLC
January 25, 2025
Company
BeiGene Outlines Global R&D Strategy at J.P. Morgan Healthcare Summit
January 25, 2025
Company
Deals
Evopoint Biosciences Licenses SOS1 Inhibitor to METiS Therapeutics
January 25, 2025
Company
Drug
Pfizer’s Nurtec ODT Launches in China via Hainan’s Bo’Ao Lecheng Zone
January 25, 2025
1
2
…
9
10
11
12
13
…
19
20
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?